Health News Releases

  • Today December 21
June 27, 2018 16:00
United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™
Masimo (NASDAQ: MASI) announced today that the United Arab Emirates (UAE) Ministry of Health & Prevention (MOHAP) is adopting a national screening protocol for critical congenital heart disease (CCHD)
June 27, 2018 14:00
22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, announced today that the Company has exclusively
June 26, 2018 09:25
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that both randomised controlled trials in the EASE phase III programme, investigating the use of empagliflozin in combination
June 25, 2018 10:00
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the founda
June 19, 2018 13:45
Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A
Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing authorisation for its human cell line-derived recombinant factor VIII (rFVIII) product, Nuwiq
June 15, 2018 13:25
Brightree Announces eReferral Integration with athenahealth
Brightree, the leading provider of cloud-based software helping post-acute care companies improve business performance and patient outcomes, announced the release of a new solution that allows home me
June 12, 2018 14:45
New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo Patient State Index (PSi), a processed EEG parameter provided b
June 11, 2018 10:25
Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) announces that it has today entered into a term loan credit agreement for an aggregate principal amount of up to 7.5 billion USD with leadi
June 08, 2018 10:55
Impossible Foods Checks in to Hong Kong Hotels
Impossible Foods is offering its award-winning, plant-based meat at three of Hong Kong’s top-ranking hotels: Hotel ICON, Grand Hyatt Hong Kong, and InterContinental Grand Stanford Hong Kong. Imposs
June 07, 2018 15:15
Sonion and Valencell Partner to Make Biometrics Universal in Hearables and Hearing Health Markets
Sonion, the global leader in micro acoustic and micro mechanical technologies and solutions for hearing instruments and specialty earphones, and Valencell, the leading innovator in wearable biometric
June 06, 2018 12:40
Nerviano Medical Sciences Announces Collaboration and License Agreement with Merck to Discover Small Molecule Inhibitors of Certain Anticancer Targets
Today Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in Europe, announced an agreem
June 05, 2018 14:00
New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP) therapy to a more advanced bilevel device in the first 90 days of treatment is an effecti
June 05, 2018 11:50
New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
Masimo (NASDAQ:MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®) to intermittent an
June 04, 2018 14:00
Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
Celgene Corporation (NASDAQ:CELG) today announced additional results from RELEVANCE, a phase III, randomized, open-label, international clinical study conducted in partnership with the Lymphoma Academ
June 04, 2018 13:40
BRIC INVEST Offers Aimedis - AIM ICO: Leveraging Blockchain and AI for a Sound eHealth Investment
Dutch eHealth-provider Aimedis, creator of a blockchain and AI-based platform that allows patients and institutions to safely store and share health information, such as diagnoses, x-rays, blood scree
June 04, 2018 11:50
Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relapsed or Refractory Multiple Myeloma
Celgene Corporation (NASDAQ:CELG) today announced results from the OPTIMISMM study, a phase III, randomized, open-label, international clinical study of the investigational combination regimen of POMA
May 30, 2018 11:45
ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies
ResMed (NYSE:RMD, ASX:RMD), a global leader in connected healthcare solutions, today announced it has entered into a definitive agreement to acquire privately held HEALTHCAREfirst, a provider of softw
May 30, 2018 09:50
Large-Scale Study Provides First-Ever Insights into the Genetic Causes of Bedwetting
New evidence from the world’s first genome-wide association study (GWAS) identifies genes and genetic variants associated with bedwetting and may lead to earlier identification of children predisposed
May 29, 2018 11:30
Octapharma Share Promising Preclinical Data for SubQ-8, a Novel Subcutaneous Recombinant FVIII, at WFH 2018
Octapharma announced today that pre-clinical data for SubQ-8 were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World Congress in Glasgow, UK. SubQ-8, currently
May 29, 2018 11:20
Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress
Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a symposium at the recent World Federation of Hemophilia (WFH) 2018 World Congre
May 25, 2018 19:10
Public Health Leaders Urge FDA to Issue Final Rule for Reducing Nicotine in Cigarettes by March 2019
22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, announced today that 41 public health and medical org
May 25, 2018 11:30
ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy
Remote patient monitoring and resupply programs have been shown to improve patient adherence to positive airway pressure (PAP) therapy, according to two separate studies presented by ResMed (NYSE: RMD
May 25, 2018 10:25
Geltor Inc. Wins Prestigious 2018 CEW Innovation Award
Geltor, Inc., the ingredient design company, was named the winner of the 2018 CEW Beauty “Innovation of the Year” Award. The CEW Beauty Awards are the industry’s highest honor and have elevated the mo
May 24, 2018 11:45
Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease
For media excluding US/Canada and UK Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical acti
May 23, 2018 20:35
Efficacy and safety of OFEV® reinforced in new presentations at ATS 2018
Boehringer Ingelheim today announced new presentations at the American Thoracic Society’s 2018 annual conference that reinforce the efficacy, safety and tolerability profile of OFEV® (nintedanib) in p
25 per page50 per page75 per page100 per page